Thanks dma......VCR and HTW have not yet been affected by last...

Thanks dma......VCR and HTW have not yet been affected by last weeks milestone. Should be soon!

........."That will accelerate the growth of the market for VADs, and that should have flow-on effects for HeartWare and Ventracor."

Ventracor chief executive Peter Crosby said that the panel recommendation would boost Ventracor's position, as his company's device was testing favourably compared to the Heartmate II.

"The early clinical results of the VentrAssist compare very favourably with those of the Heartmate II and we are optimistic the US clinical trials of the VentrAssist will yield very positive results," Crosby said.